Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
read more
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
900
900
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
Pioneering Multiplex In-Vivo CAR-T Therapy
The first technology enabling complex, multi-gene therapeutic constructs delivered directly in vivo with weeks-long precision expression.
Breakthrough Science
MultiPlex genetic engineering previously thought impossible in vivo
Redefining What's Possible in Cell Therapy
"We envision a world where the most advanced cell therapies are as accessible as traditional biologics – delivered directly in the patient with the precision of genetic medicine and the potency of engineered immunity."
Three Pillars to our approach
Breakthrough Science
MultiPlex genetic engineering previously thought impossible in vivo
Transformative Impact
From complex manufacturing to simple injection – revolutionizing patient access
Limitless Potential
Therapeutic applications spanning oncology, autoimmunity, and beyond
In the News
The Latest from Chimeron Bio
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
read more
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
750
750
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
read more
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
300
300
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
Chimeron Bio Welcomes Kevin Heyeck as New CEO
read more
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
300
300
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
read more
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp
206
206
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp